Salud financiera de hoja de balance de Sun Pharmaceutical Industries
Salud financiera controles de criterios 6/6
Sun Pharmaceutical Industries tiene un patrimonio de accionistas total de ₹632.0B y una deuda total de ₹19.3B, lo que sitúa su ratio deuda-patrimonio en 3.1%. Sus activos y pasivos totales son ₹794.4B y ₹162.4B respectivamente. El BAIT de Sun Pharmaceutical Industries es de ₹102.1B, por lo que su ratio de cobertura de intereses es de -37.3. Tiene efectivo e inversiones a corto plazo que ascienden a ₹148.3B.
Información clave
3.1%
Ratio deuda-patrimonio
₹19.28b
Deuda
| Ratio de cobertura de intereses | -37.3x |
| Efectivo | ₹148.33b |
| Patrimonio | ₹631.97b |
| Total pasivo | ₹162.44b |
| Activos totales | ₹794.41b |
Actualizaciones recientes sobre salud financiera
Sun Pharmaceutical Industries (NSE:SUNPHARMA) Has A Rock Solid Balance Sheet
Mar 13
We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Can Manage Its Debt With Ease
Jun 15Is Sun Pharmaceutical Industries (NSE:SUNPHARMA) A Risky Investment?
Mar 14These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Reasonably Well
Dec 09These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Safely
Sep 04Does Sun Pharmaceutical Industries (NSE:SUNPHARMA) Have A Healthy Balance Sheet?
Jun 02Recent updates
Sun Pharmaceutical Industries (NSE:SUNPHARMA) Has A Rock Solid Balance Sheet
Mar 13Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming Dividend Will Be Larger Than Last Year's
Feb 03Here's Why We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Might Deserve Your Attention Today
Jan 05Getting In Cheap On Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Is Unlikely
Dec 18Is Now The Time To Put Sun Pharmaceutical Industries (NSE:SUNPHARMA) On Your Watchlist?
Oct 04Should You Be Adding Sun Pharmaceutical Industries (NSE:SUNPHARMA) To Your Watchlist Today?
Jul 03We Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Can Manage Its Debt With Ease
Jun 15Is Sun Pharmaceutical Industries (NSE:SUNPHARMA) A Risky Investment?
Mar 14Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Increasing Its Dividend To ₹7.50
Feb 03These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Reasonably Well
Dec 09Does This Valuation Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Imply Investors Are Overpaying?
Oct 13These 4 Measures Indicate That Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Using Debt Safely
Sep 04Sun Pharmaceutical Industries' (NSE:SUNPHARMA) Upcoming Dividend Will Be Larger Than Last Year's
Aug 05Estimating The Intrinsic Value Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
Jul 12Does Sun Pharmaceutical Industries (NSE:SUNPHARMA) Have A Healthy Balance Sheet?
Jun 02Is Now The Time To Put Sun Pharmaceutical Industries (NSE:SUNPHARMA) On Your Watchlist?
Apr 28Are Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Investors Paying Above The Intrinsic Value?
Apr 09Sun Pharmaceutical Industries (NSE:SUNPHARMA) Is Increasing Its Dividend To ₹7.00
Feb 02Is Sun Pharmaceutical Industries (NSE:SUNPHARMA) Using Too Much Debt?
Feb 02Should You Be Adding Sun Pharmaceutical Industries (NSE:SUNPHARMA) To Your Watchlist Today?
Jan 19Estimating The Intrinsic Value Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
Dec 27Sun Pharmaceutical Industries (NSE:SUNPHARMA) Seems To Use Debt Rather Sparingly
Nov 04Here's Why I Think Sun Pharmaceutical Industries (NSE:SUNPHARMA) Might Deserve Your Attention Today
Oct 21Calculating The Intrinsic Value Of Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
Sep 27Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹393.5B) de SUNPHARMA superan a sus pasivos a corto plazo (₹150.2B).
Pasivo a largo plazo: Los activos a corto plazo de SUNPHARMA (₹393.5B) superan a sus pasivos a largo plazo (₹12.2B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: SUNPHARMA tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de SUNPHARMA ha pasado de 23.6% a 3.1% en los últimos 5 años.
Cobertura de la deuda: La deuda de SUNPHARMA está bien cubierta por el flujo de caja operativo (602.5%).
Cobertura de intereses: SUNPHARMA gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.